Clinical Trials Directory

Trials / Completed

CompletedNCT00218335

A Network & Dyad HIV Prevention Intervention for IDU's - 1

A Network & Dyad HIV Prevention Intervention for IDU's

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
1,024 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.

Detailed description

HIV seroincidence among injection drug users remains high, with unprotected sexual contact substantially contributing to new HIV infections among injection drug users (IDUs). Interventions that are culturally competent and target drug users' main sex and drug partners may be especially effective for HIV/STI and HCV control and prevention. The intervention to be tested in this study draws upon theoretical and empirical evidence suggesting that peer educator programs can have significant effects on the risk-related behaviors of both the educators and the peers whom they educate. Specifically, through group and individual focused sessions, participants learn and practice skills designed to reduce drug and sex related risk behaviors. Furthermore, individuals and their main risk partners attend a training session that focuses on risk reduction within their relationship.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntervention ConditionIn the intervention Condition participants were trained to be Health Educators. The intervention focused on HIV risk reduction by teaching knowledge and skills to reduce injection, drug splitting, and sex risk, and by teaching communication skills to conduct outreach to personal risk network members. The intervention consisted of five group-based sessions, one individual session, and one dyad session with a risk network member.
BEHAVIORALControl ConditionThe control condition focused on injection drug-use related topics (e.g. HIV testing, Hepatitis C and drug overdose). The sessions were educational and did not include skills training. The control condition consisted of five group-based sessions.

Timeline

Start date
2003-06-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2005-09-22
Last updated
2013-04-18
Results posted
2013-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00218335. Inclusion in this directory is not an endorsement.